Q2 STOCKS TO BUY

Analysts Are Buying This Biotech's Sell-Off

Karyopharm Therapeutics bounced near the $10 level in recent weeks

Nov 9, 2018 at 1:55 PM
facebook X logo linkedin


Yesterday, Karyopharm Therapeutics Inc (NASDAQ:KPTI) closed down 3.1% following the company's third-quarter results. However, not everyone's throwing in the towel on KPTI. In fact, Wedbush just moved in and upgraded the shares to "outperform" from "neutral" based on its belief that the shares are at an "attractive entry point." And though it trimmed its price target to $24 from $25, RBC is staying positive on the equity.

Most other analysts are already very bullish on the security, with six of the eight in coverage handing out "strong buy" recommendations. Also, the average 12-month price target of $23.90 is more than double the shares' price today of $11.76.

Looking elsewhere, however, many are gearing up for more downside for KPTI. Short interest jumped by 33.9% in the last reporting period. This puts 13.8% of the total float in the hands of short sellers, which would take 6.5 sessions to cover, based on average daily volumes.

Looking closer at Karyopharm Therapeutics' chart, the stock has struggled in recent months, falling from an Aug. 30 three-year high of $21.71, recently bottoming near the round $10 level, a price point that also acted as a floor back in January. Also, the 20-day moving average is starting to flatten, hinting at a potential trend change for KPTI.

kpti stock price

 
 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.

 

 
 

Follow us on X, Follow us on Twitter